Boardroom Alpha
Boardroom Alpha
DLB · Additional Proxy Materials (DEFA14A) · Filed December 16, 2025

Dolby Laboratories Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
December 16, 2025
Ticker
DLB
Accession
0001193125-25-320034
Boardroom Alpha · Filing insights

Dolby Laboratories urges shareholders to support its eight-director slate, approve executive compensation, and ratify the auditor.

About Dolby Laboratories Inc
Market cap
$5.3B
1Y TSR
−23.4%
3Y TSR
−10.9%
Board grade
D
Sector
Industrials
CEO
Kevin J Yeaman
Last annual meeting: Feb 3, 2026 · View full Dolby Laboratories Inc profile →
DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

Filed by the Registrant 

Filed by a Party other than the Registrant 

Check the appropriate box:

 

 

Preliminary Proxy Statement

 

 

Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

 

Definitive Proxy Statement

 

 

Definitive Additional Materials

 

 

Soliciting Material Pursuant to § 240.14a-12

DOLBY LABORATORIES, INC.

 

(Name of Registrant as Specified In Its Charter)

 

   

 

(Name of Person(s) Filing Proxy Statement, if Other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

 

No fee required.

 

 

Fee paid previously with preliminary materials.

 

 

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.


LOGO

 

                
                   
   

 

Your Vote Counts!

      

 

    LOGO

 

 

DOLBY LABORATORIES, INC.

 

2026 Annual Meeting

Vote by February 02, 2026

11:59 PM ET

 

   
 

LOGO     

 

 

   
   
   
   
   

   
            
         

You invested in DOLBY LABORATORIES, INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the shareholder meeting to be held on February 03, 2026.

Get informed before you vote

View the Annual Report, Notice & Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to January 20, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

LOGO

 

 

*If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.ProxyVote.com or request a paper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance.


Vote at www.ProxyVote.com

   Control # XXXX XXXX XXXX XXXX

 

 

 

THIS IS NOT A VOTABLE BALLOT

 

This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters.

   LOGO

 

 Voting Items  

Board

Recommends

 
 1.     Election of Directors  
 
   Nominees:  
 
 01   

Kevin Yeaman

  LOGO For
 
 02   

Peter Gotcher

  LOGO For
 
 03   

David Dolby

  LOGO For
 
 04   

Tony Prophet

  LOGO For
 
 05   

Emily Rollins

  LOGO For
 
 06   

Simon Segars

  LOGO For
 
 07   

Anjali Sud

  LOGO For
 
 08   

Avadis Tevanian, Jr.

  LOGO For
 
 2    An advisory vote to approve Named Executive Officer compensation.   LOGO For
 
 3    Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 25, 2026.   LOGO For

NOTE: Such other business as may properly come before the meeting and any postponement, adjournment, or continuation thereof.

 

  

Under New York Stock Exchange rules, brokers may vote “routine” matters at their discretion if your voting instructions are not communicated to us at least 10 days before the meeting. We will nevertheless follow your instructions, even if the broker’s discretionary vote has already been given, provided your instructions are received prior to the meeting date.

 

  FLASHID-JOB#   

1.00000

322,224

148,294

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Dolby Laboratories Inc (DLB)

Reference

Frequently asked questions

When did Dolby Laboratories Inc file this DEFA14A?
Dolby Laboratories Inc (DLB) filed this Additional Proxy Materials (DEFA14A) with the SEC on December 16, 2025. The accession number assigned by EDGAR is 0001193125-25-320034.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Dolby Laboratories urges shareholders to support its eight-director slate, approve executive compensation, and ratify the auditor. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Dolby Laboratories Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Dolby Laboratories Inc has filed under CIK 1308547, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer